Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prekallikrein (PK), also known as Fletcher factor, is a serine protease precursor (zymogen) found in plasma. It is the inactive precursor of plasma kallikrein, an enzyme that plays a central role in the intrinsic pathway of blood coagulation and in the generation of bradykinin, a potent vasoactive peptide. It is activated to kallikrein by activated Factor XII (FXIIa) which is a key step in initiating intrinsic coagulation and inflammatory responses. Its deficiency causes markedly prolonged activated partial thromboplastin time (aPTT) but typically does not result in bleeding symptoms.
N/A (Prekallikrein is a zymogen, not typically directly targeted by drugs. However, its activation to kallikrein is a key step)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prekallikrein (PK).